Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121)
- PMID: 11333271
- DOI: 10.1074/jbc.M102315200
Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121)
Abstract
The two most abundant secreted isoforms of vascular endothelial growth factor A (VEGF(165) and VEGF(121)) are formed as a result of differential splicing of the VEGF-A gene. VEGF(165) and VEGF(121) share similar affinities at the isolated VEGF receptor (VEGFR)-2 but have been previously demonstrated to have differential ability to activate VEGFR-2-mediated effects on endothelial cells. Herein we investigate whether the recently described VEGF(165) isoform-specific receptor neuropilin-1 (Npn-1) is responsible for the difference in potency observed for these ligands. We demonstrate that although VEGFR-2 and Npn-1 form a complex, this complex does not result in an increase in VEGF(165) binding affinity. Therefore, the differential activity of VEGF(165) and VEGF(121) cannot be explained by a differential binding affinity for the complex. Using an antagonist that competes for VEGF(165) binding at the VEGFR-2.Npn-1 complex, we observe specific antagonism of VEGF(165)-meditated phosphorylation of VEGFR-2 without affecting the VEGF(121) response. These data indicate that the formation of the complex is responsible for the increased potency of VEGF(165) versus VEGF(121). Taken together, these data suggest a receptor-clustering role for Npn-1, as opposed to Npn-1 behaving as an affinity-converting subunit.
Similar articles
-
Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165.J Biol Chem. 2002 May 17;277(20):18069-76. doi: 10.1074/jbc.M201681200. Epub 2002 Mar 8. J Biol Chem. 2002. PMID: 11886873
-
VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding.J Cell Biochem. 2002;85(2):357-68. doi: 10.1002/jcb.10140. J Cell Biochem. 2002. PMID: 11948691
-
Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1.Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3071-6. doi: 10.1073/pnas.96.6.3071. Proc Natl Acad Sci U S A. 1999. PMID: 10077638 Free PMC article.
-
The splice variants of vascular endothelial growth factor (VEGF) and their receptors.J Cell Sci. 2001 Mar;114(Pt 5):853-65. doi: 10.1242/jcs.114.5.853. J Cell Sci. 2001. PMID: 11181169 Review.
-
Signaling pathways induced by vascular endothelial growth factor (review).Int J Mol Med. 2000 May;5(5):447-56. doi: 10.3892/ijmm.5.5.447. Int J Mol Med. 2000. PMID: 10762646 Review.
Cited by
-
VEGFA/NRP-1/GAPVD1 axis promotes progression and cancer stemness of triple-negative breast cancer by enhancing tumor cell-macrophage crosstalk.Int J Biol Sci. 2024 Jan 1;20(2):446-463. doi: 10.7150/ijbs.86085. eCollection 2024. Int J Biol Sci. 2024. PMID: 38169627 Free PMC article.
-
Neuropilin-1 is essential for vascular endothelial growth factor A-mediated increase of sensory neuron activity and development of pain-like behaviors.Pain. 2023 Dec 1;164(12):2696-2710. doi: 10.1097/j.pain.0000000000002970. Epub 2023 Jun 27. Pain. 2023. PMID: 37366599
-
Clinical impact of soluble Neuropilin-1 in ovarian cancer patients and its association with its circulating ligands of the HGF/c-MET axis.Front Oncol. 2022 Oct 21;12:974885. doi: 10.3389/fonc.2022.974885. eCollection 2022. Front Oncol. 2022. PMID: 36338759 Free PMC article.
-
From protein-protein interactions to immune modulation: Therapeutic prospects of targeting Neuropilin-1 in high-grade glioma.Front Immunol. 2022 Sep 20;13:958620. doi: 10.3389/fimmu.2022.958620. eCollection 2022. Front Immunol. 2022. PMID: 36203599 Free PMC article. Review.
-
Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/VEGFR-2 interaction.Oncogene. 2022 Apr;41(15):2254-2264. doi: 10.1038/s41388-022-02244-7. Epub 2022 Feb 26. Oncogene. 2022. PMID: 35217792
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
